Obesity rates for U.S. adults continue to drop—potentially from the rise of GLP-1 drugs like Ozempic. Should grocers be worried about changing eating habits? Let us know your thoughts in our LinkedIn poll here.
You are subscribed to this newsletter as newsletter@newslettercollector.com To be removed from this list please update your preferences or unsubscribe.